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Abstract Mesenchymal stem cells are often transplanted
into inflammatory environments where they are able to
survive and modulate host immune responses through a
poorly understood mechanism. In this paper we analyzed the
responses of MSC to IL-1β: a representative inflammatory
mediator. Microarray analysis of MSC treated with IL-1β
revealed that this cytokine activateds a set of genes related to
biological processes such as cell survival, cell migration, cell
adhesion, chemokine production, induction of angiogenesis
and modulation of the immune response. Further more
detailed analysis by real-time PCR and functional assays
revealed that IL-1β mainly increaseds the production of
chemokines such as CCL5, CCL20, CXCL1, CXCL3,
CXCL5, CXCL6, CXCL10, CXCL11 and CX3CL1, interleu-
kins IL-6, IL-8, IL23A, IL32, Toll-like receptors TLR2,
TLR4, CLDN1, metalloproteins MMP1 and MMP3, growth
factors CSF2 and TNF-α, together with adhesion molecules
ICAM1 and ICAM4. Functional analysis of MSC prolifera-
tion, migration and adhesion to extracellular matrix compo-
nents revealed that IL-1β did not affect proliferation but also
served to induce the secretion of trophic factors and adhesion
to ECM components such as collagen and laminin. IL-1β
treatment enhanced the ability of MSC to recruit monocytes
and granulocytes in vitro. Blockade of NF-κβ transcription
factor activation with IκB kinase beta (IKKβ) shRNA
impaired MSC migration, adhesion and leucocyte recruitment,
induced by IL-1β demonstrating that NF-κB pathway is an
important downstream regulator of these responses. These
findings are relevant to understanding the biological responses
of MSC to inflammatory environments.
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Introduction
Mesenchymal stem cells have become a therapeutic option for
several pathologies like myocardial infarction, osteogenesis
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imperfecta, graft versus host disease and wound healing [1–4].
As a part of the cell therapy, MSC are often transplanted in
ischemic, apoptotic and/or inflammatory environments where
cells survive and promote tissue regeneration by mechanisms
that remain poorly understood. These cells are immunoprivi-
leged, and in most of pathologies the induced potential benefits
are related to paracrine activity mediated by their ability to
survive in ischemic and inflammatory environments [5–7].
Despite their therapeutic potential initial, clinical results have
been disappointing due to reported low benefits. It is believed
that in adequate doses, low engraftment and poor survival
are responsible for these results. We and others reported that
intramyocardial MSC transplantation recruits a number of
inflammatory cells that contribute to the healing of the infarct
[8, 9]. Transplanted cells are consistently exposed to tissue
signals, immune cells and mediators that could influence
their behaviour. Since successful application of stem cell
approaches will depend on the microenvironment of the
recipient tissue, we have sought to investigate the response of
MSC to an inflammatory environment. Previous reports
showed that proinflammatory cytokines were able to in-
creased migration of human MSC to many chemotactic
factors [10], to induce MSC to produce chemokines
[11] and to stimulate MSC to differentiate into neural
phenotype [12]. Following this rationale we cultured
MSC in the presence of inflammatory mediators and
analyzed biological responses implicated in proliferation,
survival, adhesion and migration that could aid to predict
their response in these environments. We focused our
studies in IL-1β as a prototypical inflammatory mediator
and the results showed that this cytokines promotes
specific biological processes in MSC in part due to
activation of the transcription factor NF-κB (Nuclear
Factor KAPPA-light-chain-enhancer of activated B cells).
Materials and Methods
Cells and Culture Conditions
Human bone marrow MSC (n04; Inbiomed, San Sebastian,
Guipuzcoa, Spain) were cultured following manufacturers´
instructions. After centrifugation cells were seeded in tissue
culture flasks in low glucose Dulbecco’s modified Eagle
medium (Sigma-Aldrich, St. Louis, MO; htpp://www.
sigmaaldrich.com), supplemented with 10% fetal calf
serum (Thermo Scientific Hyclone, Rockford, IL; htpp://
www.piercenet.com), 4 mM L-Glutamine (Gibco, Grand
Island, NY; htpp://www.invitrogen.com) and 1% antibiotics
[50U/mL penicillin, 50 μg/mL streptomycin (Gibco)]. Cells
were maintained in a humidified atmosphere of 95% air and
5% CO2 at 37°C. The medium was replaced every 3 days.
IL-1β (25 ng/mL), (Millipore, Temecula, CA; htpp://
www.milipore.com), IL-6 (20 ng/mL), (R&D Systems,
McKinley Place, MN; htpp://www.RnDSystems.com), IL-
8 (20 ng/mL), (Sigma-Aldrich) and TNF-α (50 ng/mL),
(Sigma-Aldrich) were added and maintained during different
periods of time depending on the experiments.
Electrophoresis and Western blotting
Cells were submitted to serum deprivation for 18 h before
incubation with IL-1β (25 ng/mL) for 30 min. Cells were
then washed with PBS and the monolayer lysed in M-PER®
Mammalian Protein Extraction Reagent (Thermo Fisher
Scientific, Rockford, IL; htpp://www.piercenet.com)
containing protease inhibitors (Roche, Mannheim, Germany;
htpp://www.roche.com)] and phosphatase inhibitors [Sodium
Orthovanadate 1 mM (Sigma-Aldrich), Sodium Fluoride
1 mM (Sigma-Aldrich)]. Protein concentration was quantified
using the Pierce® BCA Protein Assay Kit (Thermo Fisher
Scientific). For western blotting 30 μg of protein was loaded
and separated by 10% SDS-PAGE, before transfer to a PVDF
membrane (Thermo Scientific) and blockinged with 5%
BLOT-Quick Blocker (Millipore). Primary antibodies were
incubated at 4°C overnight. After, the blots were incubated
with IgG HRP Conjugated for 1 h at room temperature.
Detection was performed with ECL system [ECL PlusTM
Western Blotting Detection Reagents Amersham (GE health-
care, Bukinghamshire, UK; htpp://www.gehealthcare.com)].
GAPDH was used to determine equal protein loading.
Antibodies used were anti-phospho-Akt 1/2/3 (Ser473),
anti-phospho-NFκβ p65 (Ser536) (Cell Signaling Tecnology
Inc., Danvers, MA; htpp://www.cellsignaling.com), anti-
GAPHD, anti-ERK 1/2 (MAPK), anti-phospho-ERK 1/2
(MAPK), (Chemicon, Temecula, CA; htpp://www.chemicon.-
com), anti-Akt 1/2/3, anti-NFκβ(p65), anti-rabbit IgG HRP
Conjugated (Santa Cruz Biotecnology Inc., Santa cruz,
CA; htpp://www.scbt.com) and anti-mouse IgG HRP
Conjugated (Promega, Madison, WI; htpp://www.promega.
com). All antibodies used were assayed at 1:1,000 dilution
except anti-Akt 1/2/3 and anti-NFκB (p65) that were used
at 1:500.
Cell Cycle Assay
To analyze the effect of IL-1β in cell cycle, 106 cells were
harvested, fixed with 70% EtOH and kept at −20°C until use.
Fixed cells were centrifugated and resuspended in 50 μg/mL
propidium bromide (Sigma-Aldrich) and analyzed by flow
cytometry (488 nm excitation, 625 nm emission).
MTT Proliferation Assay
Cell proliferation was determined using a 3-(4, 5-
dimethylthiazol-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium
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bromide (MTT) assay. MSC were plated at a density of
104 cells/cm2 in 96-well microplates. 24 h post seeding,
cells were treated with recombinant IL-1β (25 ng/mL) or
IL-6 (20 ng/mL) for 24 h. Proliferation was assayed by
Thiazolyl Blue Tetrazolium Bromide (Sigma-Aldrich),
acording to manufacturer´s instructions. The absorbance of
the samples was measured at 570 nm using a microplate
reader (Victor3 1420 Multilabel Counter; PerkinElmer Inc.,
Waltham, MA; htpp://www.perkinelmer.com). Experiments
were performed in triplicate and results were expressed
relative to the untreated control.
Construction of IKKβ shRNA and Lentiviral Transduction
IKKβ shRNA secuences have been published previously [13]
and were purchased from Sigma-Genosys (Sigma-Aldrich): -
IKKβi: GGAAGTACCTGAACCAGTTTG. Oligos were
annealed and cloned into pSUPER plasmid carrying H1 pro-
moter using BglII-HindIII sites. The H1-shRNA expression
cassette was then excised and cloned into pLVTHM (Addgene
plasmid 12247; Addgene, Cambridge, MA, http://www.
addgene.org) using EcoRI-ClaI sites. Viral particles
were produced in human embryonic kidney 293 T cells
(ATCC, www.atcc.org). Briefly, 293 T cells were seeded
in high glucose DMEM containing 10%FBS. psPAX
(Addgene plasmid), pVSV-G (Addgene plasmid 12259,
www.addgene.org) and the lentiviral vector pLVTHM
containing GFP reporter gene and shRNA sequences
were transfected in to the packing cells using calcium
phosphate precipitation method. Viral transduction was
carried out using a multiplicity of infection (M.O.I.) of
10 in the presence of 8 μg/mL of polybrene (Sigma-
Aldrich) in order to achieve 100% infection.
MSC Migration Assay
To study trophism induced inMSC by IL-1β, cells were seeded
in basal medium (DMEM with 0.5% FBS) at 10,000 cells/cm2
in the top chamber of an 8 μm-pore migration transwell (BD
Falcon, Bedford, MA, htpp://www.bd.com). After overnight
culture, 25 ng/mL of IL-1β was added to the bottom chamber
and cells were fixed with 2% paraformaldehide (Panreac
Química, Castellar del Vallés, Spain), SDF-1α (20 ng/mL)
and 10% FBS were used as positive controls. Briefly, after
4 h non migrated cells were removed from the upper side
of the membrane using a cotton bud to remove non
migrating cells, the membrane was cut and placed in a
glass slide with the bottom side upwards and before
staining with 4´,6 diamidino-2 phenyilindole (DAPI)
(Sigma-Aldrich). All assays were performed in duplicated
wells and repeated three times. Migrated cells were counted
as fold increase relative to passive MSC cell migration in
untreated wells.
Leucocyte Migration Assay
To determine the nature of human leucocytes that could be
recruited in response to paracrine factors secreted by MSC,
we established co-culture of MSC and pheripheral blood
leucocytes (PBLs) using a transwell culture system (BD
Falcon). MSC (10,000 cells/cm2) seeded in the lower chamber
of the transwells were stimulated or not with IL-1β for 2 h.
After extensive washes with PBS, wells were filled with fresh
medium and human PBLs from buffy coats (100,000 cells)
were seeded in the upper chamber. Migrated cells through
8 μm-pore size membranes were counted after 5 h of co-
culture. Cells were fixed as described above and leucocyte
populations were quantified in hematoxilin stained preparation
by morphologic counting. All studies were performed in a
blinded fashion.
Adhesion Assay
Cells were seeded in basal medium onto cover slides previously
treated with 10 μg/cm² of fibronectin (Sigma-Aldrich),
2 μg/cm² of laminin (Sigma-Aldrich) and 10 μg/cm²
of collagen (Sigma-Aldrich). After 1 h, cells were fixed
with 2% paraformaldehyde, washed with PBS, labelled
with 4´,6-diamidino-2-phenylindole (DAPI) and counted.
Reverse Transcription and Real-Time Quantitative PCR
MSC incubated in different conditions were washed with
PBS. RNAwas extracted using TRIzol Reagent (Invitrogen,
Carlsbad, CA; htpp://www.invitrogen.com) and purified
with RNeasy Plus Mini Kit (Qiagen, Dusseldorf, Germany;
htpp://www.qiagen.com). RNA samples were quantified by
spectrometry (NanoDrop ND-1000, NanoDrop Technologies,
Wilmington, DE; htpp://www.nanodrop.com) and integrity
was assessed by agarose gel electrophoresis and the absorbance
ratio 260/280 nm. cDNA was obtained by retrotranscriptase
reverse transcription using M-MLV Reverse Transcriptase
(Invitrogen) from total RNA (1 μg). Primers were designed
using the Primer-Blast online tool (Table 1). The Ct of each
PCR in a reference human MSC cDNA sample (dilution 1/10)
is expressed as mean ± standard deviation (SD) of three
independent PCR experiments. Real-time PCR was performed
using convenient primers and SYBR Green I [1X LightCycler
480 SYBR Green I Master (Roche Molecular Biochemical,
Mannheim, Germany; htpp://www.roche.com)]. Plates were
run in a real-time thermal cycler (LightCycler 480 Instrument;
Roche Diagnostics, Mannhein, Germany, htpp://www.roche.
com) following manufacturer´s instructions. Real-time
monitoring of the PCR reaction was performed with the
LightCycler 480 Software 1.5, as well as the quantification of
the products in the exponential phase of the amplification.
Relative expression levels were calculated with the Relative
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Table 1 List of oligonucleotides used for Real time-PCR. Ct and efficiency values are indicated
Gene Forward primer Reverse primer Size (bp) Ct SD Ct Efficencya
ACTB AGAGCCTCGCCTTTGCCGATCC CATGCCGGAGCCGTTGTCGAC 101 16.10 0.025 1.971
CCL2 TCTCAGTGCAGAGGCTCGCGA CCACTTCTGCTTGGGGTCAGCAC 119 17.01 0.006 1.977
CCL3 TTCAGAAGGACACGGGCAGCAGACA GGAATCTGCCGGGAGGTGTAGCT 216 29.64 0.050 1.862
CCL5 TACATTGCCCGCCCACTGCC GGGTTGGCACACACTTGGCG 119 23.82 0.052 2.061
CCL7 CAGCTGCTTTCAGCCCCCAGG GCTTCCCGGGGACAGTGGCTA 148 23.93 0.032 1.923
CCL8 TGGCAGCCACTTTCAGCCCT GCACAGACCTCCTTGCCCCG 190 27.98 0.167 2.040
CCL20 TCTGCGGCGAATCAGAAGCAGC TTCATTGGCCAGCTGCCGTGT 110 21.19 0.068 2.16
CLDN1 CCGGGTTGCCCACCTGCAAA CGTACATGGCCTGGGCGGTC 258 24.49 0.148 1.862
CLDN14 GTCGCTGTGGGCAGGTGGTC AGCCTCCCCTTCCCAGCCTG 192 30.48 0.093 2.084
CSF2 TGCAGCATCTCTGCACCCGC AGGCAGGTCGGCTCCTGGAG 176 24.47 0.188 1.708
CSF3 AGACCCATGGCTGGACCTGCC GTGGCACACTCACTCACCAGCTTC 218 31.56 0.043 2.026
CX3CL1 CTGGCTGGACAGCACCACGG GCTCCTTCGGGTCGGCACAG 175 25.96 0.087 1.880
CXCL1 AGCCTGCAACATGCCAGCCA TGTGCACATACATTCCCCTGCCT 94 21.72 0.036 1.848
CXCL10 TGCAAGCCAATTTTGTCCACGTGT GCAGCCTCTGTGTGGTCCATCC 200 24.10 0.051 1.956
CXCL11 TGTCTTTGCATAGGCCCTGGGGT AGCCTTGCTTGCTTCGATTTGGGA 164 29.72 0.178 1.821
CXCL3 AATGTAAGGTCCCCCGGACCCC ACCACCCTGCAGGAAGTGTCAA 199 20.92 0.036 2.023
CXCL5 AATCTCCGCTCCTCCACCCAGT GCTCTCTCAACACAGCAGCGGC 201 28.49 0.050 1.614
CXCL6 GCACGAGGAAACCAAAGTGCTCTG GTGCAACGCAGCTCTGTCAGCA 234 26.37 0.071 1.890
ELF3 ATTTAGAGCCGGGTAGGGGAGCG GTTGCAGCCATGAGGCTACCGGAGT 132 25.68 0.088 1.912
GAPDH CCCCTCTGCTGATGCCCCCA TGACCTTGGCCAGGGGTGCT 122 16.79 0.015 1.998
IBSP GGAGTACGAATACACGGGCGCC GGTAGCCGGATGCAAAGCCAGA 222 27.12 0.049 2.018
ICAM1 CTGGTCCTGCTCGGGGCTCT GGGCTGGTCACAGGAGGTGC 126 22.42 0.094 1.638
ICAM4 AATACACTTTGCGCTGCCACGTG GGCTCCAAGCGAGCATCAGTGT 264 28.16 0.116 2.057
IL11 TGACCCGCTCTCTCCTGGCG GCACGTGCCGCAGGTAGGAC 192 24.23 0.163 1.803
IL12A CCCAAAACCTGCTGAGGGCCG TGGAGGCCAGGCAACTCCCAT 219 29.08 0.047 1.985
IL15 GCTGCTGGAAACCCCTTGCCAT TAGGTGCTTTGGGCCAACTGGG 214 28.78 0.035 1.899
IL1B AGGCACAAGGCACAACAGGCT AACAACTGACGCGGCCTGCC 277 21.12 0.110 1.965
IL23A TGGCTGTGACCCCCAAGGACTC TGCCATGGCTGGCTGGGACT 246 27.01 0.053 1.893
IL32 TTTGTGCCAGGAAGACTGCGTGC GGCTCGACATCACCTGTCCACG 215 24.41 0.078 2.004
IL34 GAACACCACCATGCCCCGGG CAGCCTGGTGACGTTGGCGA 250 24.59 0.078 1.853
IL6 CATTCTGCCCTCGAGCCCACC GGCAGCAGGCAACACCAGGA 139 17.08 0.088 1.955
IL7 GCTGCTCGCAAGTTGAGGCAATTT TTGTTGGTTGGGCTTCACCCAGG 157 26.58 0.213 1.974
IL8 CGTGGCTCTCTTGGCAGCCTTC TTCCTTGGGGTCCAGACAGAGCTC 229 15.88 0.707 2.005
ITGA9 GCAGTGACCGCTGGCCACTT GCGCACAAGGAGGAGCCGAA 182 27.63 0.098 1.969
ITGB3 TGCCGCCCTGCTCATCTGGA TCCTGCAATCGTGGCACAGGC 239 22.43 0.008 2.192
ITGB8 CTAGCGACACTCGGCCCGC CTGGACCCAGCGCAAGGCAC 292 27.76 0.023 1.850
MMP1 GTGTCTCACAGCTTCCCAGCGAC GCACTCCACATCTGGGCTGCTTC 238 25.01 0.084 2.006
NOD2 AGGCCTACCCGCAGATGCCA GTGGGAGAGAGGCTGGCCCA 298 28.04 0.172 2.062
SDC4 CGGAGTCGCCGAGTCGATCC GGCTCCCAGACCCTGCCCTC 248 20.51 0.030 1.925
SELECTIN TTGTTCCTGCCAGCAGCTGCC AGGGCCAGAGACCCGAGGAG 164 17.64 0.085 2.030
SERPINE1 AGGACGAACCGCCAATCGCAAG ACCCTCACCCCGAAGTCTGAGG 167 25.86 0.034 2.120
TCAM1P CGAGCTTGGCTGTGGCCTCC TCTCCGCCATCCCAGCCTCC 225 27.05 0.078 1.856
TLR2 AGGCAGCGAGAAAGCGCAGC CCCCCAAGACCCACACCATCCA 253 31.23 0.352 2.162
TLR4 CCCTGCGTGGAGGTGGTTCCTA CTCCCAGGGCTAAACTCTGGATGGG 280 26.45 0.024 2.007
TNF CCCTCTGGCCCAGGCAGTCA ATGGGTGGAGGGGCAGCCTT 235 21.58 0.019 2.100
VCAM1 AGGTGACGAATGAGGGGACCACA CCAGCCTCCAGAGGGCCACT 181 17.31 0.010 2.039
a PCR efficiency of each PCR was estimated from a serially diluted standard curves obtained from a reference MSC cDNA sample. The cycle
number of the crossing point CP vs. Log (dilution factor) were plotted to calculate the slope. The efficiency of each PCR was then calculated with
the equation E ¼ 10½1=slope
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Quantification Analysis software. Results were considered
to be significant with a 2-fold induction. For all real-time
experiments, gene expression levels were normalized to
two human housekeeping genes ACTB and GAPDH and
average from triplicate samples.
Microarray Assays
Human bone marrow MSC were treated or not with IL-1β
(25 ng/mL) for 24 h at 37°C in a humidified incubator with 5%
CO2. Cells were collected and total RNAwas extracted using
the High Pure RNA Isolation kit (Roche) and quantified by
spectrometry (NanoDrop ND-1000, NanoDrop Technologies).
800 ng of total RNA were used to produce Cyanine 3-
CTP-labeled cRNA using the Low RNA Input Linear Ampli-
fication Kit PLUS (Agilent, Santa Clara, CA¸ http://www.
chem.agilent.com). Based on the protocol for One-Color
Microarray-Based Gene Expression Analysis Version 5.5
(Agilent p/n 5188–5977), 3 μg of labeled cRNA was hybrid-
ized with Whole Human Genome Oligo Microarray Kit
(Agilent p/n G4112F) containing 41,000+ unique human
genes and transcripts. Arrays were scanned in an Agilent
Microarray Scanner (Agilent G2565BA) according to the
manufacturer’s protocol and data extracted using Agilent
Feature Extraction Software 9.5.1. Hybridization was
performed by the microarray core facility from Centre
Principe Felipe.
Microarray Data Analysis
Signal was standardized across arrays using quantile normali-
zation [14]. Differential gene expression was carried out
using the fold change. Gene set analysis was carried
out for the Gene Ontology terms using FatiScan [15]
from Babelomics web tool [16]. GO annotation for the
genes in the microarray where taken from Ensembl 55
release (http://www.ensembl.org, Ensembl org, Hinxton,
UK), allowing the visualization of functional categories
within their biological context. Results were considered
to be significant with a 2-fold induction.
The microarrays data of this study have been deposited in
the Gene Expression Omnibus database under accession
number GSE33755.
Statistical Analysis
Data are expressed as mean ± SD. Comparisons between
experimental groups were done with unpaired and paired
two-samples t-test using the SPSS software (SPSS, Chicago,
IL http://www.spss.com). Differences were considered sta-
tistically significant at P<0.05.
Results
Global Transcriptome Profiling of MSC Cultured
with IL-1β
To test the effect of IL-1β onMSC, cells were cultured with or
without 25 ng/mL of IL-1β for 24 h. Gene expression changes
induced by the pro-inflammatory cytokine were evaluated by
microarray analysis. Further bioinformatics analysis using
Babelomics software (http://www.babelomics4.org) was
performed to classify genes by function using the Gene
Ontology (GO) scheme, revealing the main families of
genes affected by the treatment. Growth in IL-1β resulted in
activation of genes associated to very specific GO categories.
In particular, we identified alterations in the expression of
genes implicated in the following biological processes: i)
response to wounding, ii) immune and inflammatory re-
sponse, iii) defense response, iv) chemotaxis, v) locomotory
behaviour, vi) regulation of cell proliferation, vii) leukocyte
chemotaxix, viii) I-kappaB kinase/NF-kappaB cascade, ix)
negative regulation of apoptosis, x) blood coagulation, and
xi) cell adhesion (Table 2). Fold changes of up-regulated
genes (negative values) from enriched biological processes
in MSC treated with IL-1β (MSC-IL1β) are indicated
(Supplemental Table 1).
IL-1β Increases Expression of Multiple Chemokines
and Growth Factors in MSC
After bioinformatic analysis, highly up-regulated genes related
with these biological processes were further assayed by real-
Table 2 Enriched biological processes for up-regulated genes in
MSC-IL1β versus MSC
GO biological process Process gene set P value
GO:0009611 Response to wounding 2.00E-21
GO:0006955 Inmune response 1.74E-19
GO:0006954 Inflammatory response 2.43E-18
GO:0006952 Defense response 2.43E-17
GO:0006935 Chemotaxis 5.44E-10
GO:0007626 Locomotory behavior 6.15E-9
GO:0042127 Negative regulation of
cell proliferation
1.27E-5







GO:0007596 Blood coagulation 1.36E-2
GO:0007155 Cell adhesion 3.26E-2
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time PCR (Fig. 1, Table 3). Chemokines are small molecules
that direct the migration of immune cells via chemokine-
chemokine receptor interactions. Based on their genetic
organization and the position of two highly conserved
cysteine residues at the N-terminus, chemokines can be
divided into four subgroups, the CC, CXC, C, and
CX3C families [17]. Among CC chemokines, CCL5 and
CCL20 were the most up-regulated in response to IL-1β
treatment (312±27 and 187±15 fold, respectively). CXCL1,
CXCL3 and CX3CL1 were also highly expressed after IL-1β
treatment. CXCL10, CXCL11 and ELF3 were expressed
de novo upon stimulation of MSC with IL-1β (Table 3).
Regarding the cell adhesion molecules, the most important
families include the intercellular adhesion molecules
(ICAMs), the vascular adhesion molecules (VCAMs),
cadherins, and selectins. Among them, IL-1β treatment
increased expression of the integrin binding sialoprotein
(IBSP), ICAM1, ICAM4, integrin beta 3 platelet glycoprotein
IIIa (ITGB3), TCAM1P and VCAM1 as detected by
real-time PCR (Fig. 1 and Table 3). Other adhesion
molecules also showed a significant fold detected by
microarray analysis (Supplemental Table 1).
Treatment with IL-1β influenced the secretion of
interleukins and growth factors. The highest differences
in fold change were found in TNF-α, followed by IL-
8 and CSF2 levels (Fig. 1 and Table 3). Whereas TNF-
α is a master inflammatory cytokine implicated in
many biological process, IL-8 and CSF2 have more
restricted biological activities. Indeed, IL-8 has been pre-




















































IL-1β induced tanscriptional levels (Normalized values)
Fig. 1 Quantification of gene
transcription levels by qRT-
PCR analysis in MSC cultures
treated with IL-1β versus
untreated cultures. Data are
expressed as relative fold of
control (normalized values) and
represent the mean±S.D. of
three independent experiments
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Table 3 Transcriptional levels
of up-regulated genes in MSC
after treatment with IL-1β.
Normalized values of MSC-
IL1β vs non-treated MSC
were calculated and expressed
as mean±standard deviation
(SD) of three independent
PCR experiments
Chemokines Genebank number Mean Ct SD Ct Normalized values Normalized Error
CXCL1 NM_001511 21.72 0.036 89.1 5.9
CXCL3 NM_002090 20.92 0.036 154 11
CXCL5 NM_002994 28.49 0.050 8.65 0.59
CXCL6 NM_002993 26.37 0.071 16.5 1.27
CXCL10 NM_001565 24.10 0.051 2028 127
CXCL11 NM_005409 29.72 0.178 41.3 3.07
CX3CL1 NM_002996 25.96 0.087 21.1 0.76
CCL2 NM_002982 17.01 0.006 13.1 0.46
CCL3 NM_002963 29.64 0.050 29.2 15.8
CCL5 NM_002985 23.82 0.052 312 27
CCL7 NM_006273 23.93 0.032 13.1 0.90
CCL8 NM_005623 27.98 0.167 12.2 1.00
CCL20 NM_004591 21.19 0.068 187 15
Adhesion molecules
Selectin E NM_000450 17.64 0.085 0.94 0.08
VCAM-1 NM_001078.3 17.31 0.010 5.33 0.19
ICAM-1 NM_000201 22.42 0.094 24.5 0.84
ICAM-4 NM_001544.3 28.16 0.116 87.4 9.1
Syndecan 4 NM_002999.3 20.51 0.030 1.45 0.05
IBSP NM_004967.3 27.12 0.049 6.21 1.64
ITGA9 NM_002207.2 27.63 0.098 0.81 0.05
ITGB3 NM_000212.2 22.43 0.008 2.75 0.11
ITGB8 NM_002214.2 27.76 0.023 1.24 0.07
TCAM-1 NR_002947.1 27.05 0.078 2.17 0.12
Interleukines
IL1 NM_000576.2 21.12 0.110 145 41
IL6 NM_000600.3 17.08 0.088 9.99 1.12
IL7 NM_000880.3 26.58 0.213 1.29 0.27
IL8 NM_000584.3 15.88 0.707 76 14.4
IL11 NM_000641.2 24.23 0.163 0.79 0.18
IL12A NM_000882.3 29.08 0.047 1.16 0.05
IL15 NM_172175.2 28.78 0.035 2.94 0.48
IL23A NM_016584.2 27.01 0.053 25.3 7.8
IL32 NM_001012631.1 24.41 0.078 14.8 0.81
IL34 NM_152456.2 24.59 0.078 3.12 1.44
Growth factors
TNF NM_000594 21.58 0.019 243 21
CSF2 NM_000758 24.47 0.188 39.3 13.2
CSF3 NM_000759 31.56 0.043 1.16 0.03
ELF3 NM_004433 25.68 0.088 656 45
Toll-like receptors
Claudin 1 NM_021101.4 24.49 0.148 5.49 0.23
Claudin 14 NM_144492.2 30.48 0.093 1.30 0.13
NOD2 NM_022162.1 28.04 0.17 1.23 0.11
TLR2 NM_003264.3 31.23 0.352 2.29 0.12
TLR4 NM_138554.3 26.45 0.024 1.50 0.16
Metalloproteins
MMP1 NM_002421.3 25.01 0.084 162 12
MMP3 NM_002426.4 16.56 0.650 47.5 7.02
Stem Cell Rev and Rep (2012) 8:905–916 911
whereas CSF2 is implicated in monocytic differentiation
[19].
Other biological processes activated in response to IL-
1β were related to host defence and immune response.
Microarray analysis and real time PCR experiments
showed up-regulation of several Toll-like receptors (TLRs),
claudins and NOD proteins. These molecules are implicated
in the innate immune response to microbial infection.
However, recent reports have revealed that these molecule
also modulates biological processes in MSC such as differen-
tiation, migration and immunomodulatory responses [20, 21].
IL-1β Activates the NF-κB Pathway and do not Induce
MSC Proliferation
We next analyzed the effect of IL-1β on BM-MSC signal
transduction and cell proliferation. IL-1β promoted phos-
phorylation of NF-κB, but not PI3K/AKT and ERK1/2
pathways (Fig. 2a), as reported for other cell types [22].
However, in correlation with the result of the microarray
analysis (Table 2), IL-1β did not induce significant cell
proliferation as assessed by MTT assay (Fig. 2b). These
results were further confirmed by cell cycle analysis using
flow cytometry (Fig. 2c). The percentage of cells in G0-G1
was 91.16±2.71 in MSC versus 90.19±2.72 in MSC- IL-
1β. The percentage of cells in S phase was 2.28±1.21 in
MSC versus 1.60±0.46 in MSC- IL-1β, and finally the
percentage of cells in G2-M phase was 5.43±1.16 versus
6.40±1.69, respectively.
IL-1β Induced Migration and Adhesion of MSC is Mainly
Activated Through NF-κB Signaling
We and others have previously described that MSC are
able to migrate in vivo to ischemic and pro-inflammatory
environments [8, 23, 24] and it is believed that this
behaviour may underlie the ability of these cells to
accelerate wound healing. Migration of MSC towards
cytokines, chemokines and growth factors has also been
explored in vitro [10]. To test if IL-1β was able to
increase migratory ability in MSC, we cultivated MSC
in the upper chamber of a transwell and stimulated
migration by adding SDF-1α, IL-1β or 10% FBS in
the lower chamber (Fig. 3a). A negative control of for
migration was achieved using the same proportion of
fetal bovine serum (0.5% FBS) in the upper and lower
chamber. SDF-1α was used since it is a well-known
trophic factor for MSC implicated in homing to ischemic
areas [24], and 10% FBS was used as positive control
since it is a rich source in cytokines and growth factors.
Surprisingly, the migratory response of MSCs to IL-1β
was in fact more pronounced than it was to to SDF-1α
(1.68±0.21 fold increase versus 1.35±0.16), indicating a
strong promigratory role for IL-1β Maximum migration
was achieved towards FBS gradient (1.87±0.12 fold
increase). Similar levels of cell migration were observed
when TNF-α or IL-8 were used as trophic factors (not
shown), indicating that multiple inflammatory mediators






















































Fig. 2 a, Western blot analysis
of kinase phosphorylation
in MSC treated with IL-1β.
Total cell lysates (30 μg)
were separated by SDS-PAGE.
Anti-GAPDH was used as
loading control. b, MTT assay
of MSC cultures treated with
IL-1β (25 ng/mL) and IL-6
(20 ng/mL) for 24 h. Values
are expressed in fold increase
relative to control. c, Cell cycle
analysis by flow cytometry
of MSC cultures treated with
IL-1β (25 ng/mL) for 24 h.
(*P<0.05)
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next wanted to investigate whether the signaling pathways
induced by IL-1β could be directly linked to MSC migration
towards trophic factors. NF-κB transcription factors play an
important role in the balance between cell survival and
apoptosis and are involved in the regulation of cell
proliferation and differentiation of various cell types
[25]. IKKβ phosphorylates IκB molecules, the inhibitors
of NF-κB, leading to ubiquitination and proteasome
degradation of the inhibitors, and hence release and
activation of NF-κB [26]. NF-κB has previously been
described as the main transcription factor activated in
many pro-inflammatory responses [27]. In these context,
regulation of NF-κB cascade members was observed
among the biological processes most positively affected
by IL-1β treatment (Table 2) and phosphorylation of
NF-κB was induced on MSC after IL-1β treatment
(Fig. 2). Thus, we sought to evaluate the role of NF-κB
signaling in the biological responses of MSC in response to
IL-1β. For this purporse, we constructed a vector containing
shRNA targeting IKKβ that was lentiviraly transduced in
MSC. We then evaluated the migratory response to IL-1β,
SDF-1α and FBS. As shown in Fig. 3a, treatment with
IKKβ shRNA reduced trophic response ofMSC towards each
of the 3 trophic factors assayed. An increase in the basal
response of IKKβ transduced cells of 1.05±0.11 fold was
observed, and in response to trophic factors this was increased
by 1.21±0.11 towards SDF-1α, 1.45±0.06 towards IL-1β,
and 1.58±0.07 towards 10% FBS, strongly suggesting
that NF-κB signaling pathway plays a major role in MSC
trophism.
Migration and invasiveness of adherent cells is in part
mediated by changes in the affinity of cells to particular
ECM components (ECM). To test whether IL-1β had an effect
on MSC cell adhesion, we measured the adhesion of MSC to
the main components of ECM. The results showed that IL-1β
treatment increased the adhesion to collagen (3.03±0.29 fold),
fibronectin (1.75±0.11 fold) and laminin (2.79±0.15 fold)
(Fig. 4b). In similar way to migration experiments, adhesion
induced by IL1β treatment to collagen (1.75±0.15 fold),
fibronectin (1.20±0.05 fold) and laminin (1.32±0.07 fold)
was impaired in IKKβ-MSC. The fact that IKKβ expression
only affected the adhesion induced by IL-1β but not the
basal levels of adhesion to extracellular matrix components
indicates that IKKβ blocks specifically the mechanisms
induced by this cytokine, confirming the importance of NF-
κB signaling pathway in the IL-1β mediated biological
processes.
Il-1β Treatment of MSC Increases Recruitment
of Leucocytes In Vitro
MSC have been shown to recruit inflammatory cells such
as neutrophils, eosinophils, macrophages and to suppress
proliferation of cytotoxic and helper T cells through the
release of soluble factors such as HGF and TGF-β [11,
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Fig. 3 a, migration of MSC or MSC-IKKβ towards trophic factors
SDF-1α (20 ng/mL), IL-1β (25 ng/mL) and 10% FBS. b, Adhesion of
untreated MSC (black bars) and MSC-IKKβ (dashed bars) or treated
with IL-1β (white and grey bars, respectively) to collagen, fibronectin
and laminin. Data are represented as fold increase relative to MSC





































Fig. 4 Leucocyte migration assay of human PMNs using a transwell
insert culture system towards different stimuli. Upper chamber were
filled with PMNs and lower chambers were seeded with MSC (black
bars) or MSC-IKKβ (white bars) treated (dashed and grey bars,
respectively) or not with IL-1β. Migrated neutrophils, eosinophils,
lymphocytes and monocytes are presented as a mean of three
experiments±S.D. (number of migrated cells/field). *P<0.05, **P<0.01,
***P<0.001
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other tissues is accompanied by marked, paracrine mediated
leucocytic infiltration [4, 8]. In order to test whether IL-1β
treatment had a similar impact in MSC leucocyte recruitment,
we cultured control or IL-1β treated MSCs, in a transwell
system and measured the number and the type of leucocytes
that migrate through a the 8 μm pores of the membrane. After
5 h of culture, the mean number of migrated leucocyes/field
towards the MSC lower chambers were; 12.06±2.91 neutro-
phils, 6.52±2.14 eosinophils, 4.40±2.41 lymphocytes and
3.15±1.34 monocytes. However, migration towards IL-1β
treated MSCs increased the number of migrated neutrophils
(16.11±2.75, P<0.05), eosinophils (10.44±2.61, P<0.01),
lymphocytes (6.31±2.68, n.s.) and monocytes (9.85±2.94,
P<0.001) (Fig. 4). The observed increase in chemotactic
leucocyte migration induced by IL-1β treated MSC was again
impaired when MSC were transduced with IKKβ (9.78±2.29
neutrophils, 5.52±1.74 eosinophils, 3.42±1.98 lymphocytes
and 2.68±1.45 monocytes). Thus, IL-1β induced recruitment
of neutrophils, eosinophils and monocytes and NFκB plays a
mayor role in trophism exerted by MSC on these cell
populations.
Discussion
MSC have been used to treat a wide variety of diseases.
Whilst the contribution of differentiation/transdifferentiation
to tissue repair, are often minimal, other positive angiogenic
and immunomodulatory effects are exerted by MSC in
ischemic, apoptotic and pro-inflammatory environments
[6].
IL-1β is produced in different tissues, not only as a
response to pathogens, but also as a danger signals in
pathologies such as acute myocardial infarction [31], type
2 diabetes [32], neural disorders [33]. In this study we
wanted to investigate the response ofMSC to proinflammatory
stimuli in terms of survival, proliferation and induced paracrine
factors. Thus, we treatedMSCwith IL-1β and usedmicroarray
to infer the biological response, firstly by gene function and
later by direct gene set with known functional outcomes. A
range of biological responses were activated in response to IL-
1β, but perhaps, themost prominent was the potent stimulation
of secretion of chemokines and growth factors that in turn
were able to increase migration and adhesion of MSC
and to regulate recruitment of monocytes and granulocytes. It
is known that members of the CC family target primarily
monocytes and T cells, whereas CXC chemokines affect
mainly neutrophils. It has been previously reported that the
existence of different monocyte subsets expressing different
chemokine receptors display distinct migratory and functional
properties. Interestingly, the profile by MSCs in response
to chemokines secreted IL-1β, was enriched in CCL5,
CCL20 and CX3CL1, that could specifically attract not
only neutrophils and monocytes, but also monocytes
expressing CCR5, CCR6 and high levels of CX3CR1 [34].
Although leukocyte chemotaxis and lymphocyte development
are the main functional properties of chemokines, they posses
other biological activities like regulation of angiogenesis,
control of cell proliferation and alteration of the expression
of adhesion molecules. Indeed, the structural ERL domain
present in several members of the CXC chemokine family
determines their angiogenic potential [35] and the induced
chemokquines CXCL1, CXCL3, and CXCL8 (IL-8) contain
this motif. In the same context, CXCL10 is considered a “stop
signal” that limits expansion of the fibrotic reaction triggered
by TGFβ, FGF, and VEGF during myocardial healing [31].
The high levels of activation of this chemokine in MSC
(Table 3) could account for the potent ability of these cells to
control adverse remodeling during myocardial healing
[8, 36, 37].
Claudins are transmembrane proteins found in tight
juntions that participate not only in regulating tissue
barrier function and permeability but also in cell motility,
adhesion and migration [38]. Claudins (CLDN1 and
CLDN14) were up-regulated in MSC after IL-1β treatment.
A similar response has been reported in airway smoothmuscle
cells in response to IL-1β and TNFα [39], indicating similar
activation pathways. It has been described that TLR signalling
is linked to NF-κB and MAPK signalling pathways, and
that this induction mediates the secretion chemokines and
regulates immunosuppressive activity and recruitment of
innate immune cells [21, 40, 41]. TLR2 and TLR4 were up-
regulated in response to IL-1β. Similar effect had been
previously described after stimulation with LPS of
MSC from human parotid glands [42].
We also found differences between the activation pattern
of MSC in response to different inflammatory mediators.
Whereas TNFα increased preferentially CCL2 (MCP-1),
CCL5 (RANTES), CXCL1, CXCL5, CXCL8, CXCL10
and CCL11 [10], we demonstrate here that IL-1β increases
preferentially CCL3, CCL5, CCL20, CXCL1,CXCL3,
CXCL10 and CXCL11. Thus, modulation of MSC biological
responses is closely associated with culture conditions and the
presence of immune mediators influence MSC proliferation
and multipotency. In this context, culture protocols with
milieu capable of MSC expansion while preserving chromo-
some stability have been developed [43]
In summary, our findings show that IL-1β increases
migration and adhesion of MSC and promotes leucocyte
chemotaxis through MSC secretion of soluble factors. As
described in other cell types [44], IL-1β activates NF-κB
resultings in transcriptional activation of a wide variety of
genes such inflammatory mediators, adhesion molecules,
growth factor or immune response mediator. Since some of
these molecules are chemotactic for inflammatory leukocytes,
like monocytes and neutrophils, these paracrine factors
914 Stem Cell Rev and Rep (2012) 8:905–916
could facilitate infiltration of immune cells for tissue
repair when MSC are transplanted into injured tissues.
Taken together, these findings shed light onMSC behaviour
in inflammatory environments and suggest that inflammatory
mediators like IL-1β induce a response in MSC that could
trigger paracrine actions in vivo.
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